glutathione bromopyruvic acid conjugate 3-Bromopyruvic The promising anticancer drug 3-bromopyruvate
The promising anticancer drug 3 bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence based view ScienceDirect 3 Bromopyruvic acid (Bromopyruvic acid) Hexokinase II Inhibitor MedChemExpress 3 Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy dependent ferroptosis Cancer Gene Therapy 3 Bromopyruvate mediated MCT1 dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation Cancer & Metabolism Springer Nature Link
Pay in 4 interest-free payments of $6.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20



